MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

An oculogyric crisis after administation of alizapride: A tardive phenomenon?

A. Boogers (Edegem, Belgium)

Meeting: 2018 International Congress

Abstract Number: 78

Keywords: Anticholinergic medications, Eye movement

Session Information

Date: Saturday, October 6, 2018

Session Title: Drug-Induced Movement Disorders

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: We present a case of an oculogyric crisis (OGC) after administration of alizapride. Curious about this case is that the OGC only happened after she received this pharmaceutical more than 300 times.

Background: An oculogyric crisis (OGC) is a dystonic movement of the extraocular muscles, presenting mostly with an upward tonic deviation of the eyes. The upward gaze deviation can be briefly suppressed and lasts from a few minutes to multiple hours. Most often an oculogyric crisis is elicited by a pharmacological agent such as antipsychotics (e.g. clozapine), antiemetics (e.g. metoclopramide) or antiepileptics (e.g. carbamazepine).

Methods: We present a 57 year old lady that was seen for an urgent neurological consult. Since 30 minutes, she was complaining that she was forced to look at the ceiling with her eyes. The patient – known with a myelodysplasia – had received alizapride to treat her vomiting. In the past she had received multiple doses of alizapride (> 300 times), but never with any adverse effect.

Results: The complaint was a clinical presentation of an oculogyric crisis after administration of alizapride. Alizapride serves as an antiemetic by antagonizing the D2 receptors in the chemoreceptor trigger zone of the central nervous system. We administered 2 mg of biperiden which led to the resolution of the complaints quickly. Review of the recent literature did not show any case report of OGC by this agent. OGC is thought to be caused by an imbalance between dopamine and acetylcholine in the striatum, though the exact mechanism is still debated.

Conclusions: We describe an OGC after administration of alizapride. Interesting is the fact that the OGC only occurred after multiple administrations of this agent. This is why we consider this OGC a tardive phenomenon.

To cite this abstract in AMA style:

A. Boogers. An oculogyric crisis after administation of alizapride: A tardive phenomenon? [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/an-oculogyric-crisis-after-administation-of-alizapride-a-tardive-phenomenon/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/an-oculogyric-crisis-after-administation-of-alizapride-a-tardive-phenomenon/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley